Abstract
COVID-19 pandemic affected over 227 countries with more than 147 million infections that claimed 31.22 lacs lives. The first case of the pandemic was reported from China in Dec, 2019 showing pneumonia like symptoms that turned out to be the novel strain of coronavirus (2019-n- CoV). The WHO declared 2019-nCoV infection as the Public Health Emergency of International Concern and the disease named coronavirus disease (COVID-19). The infection curve of the pandemic has been flattened in many countries around the world, but the effective new antiviral drugs or vaccine has not yet developed. So far, we are saved by non-pharmaceutical interventions like handwashing, social distancing, quarantine, masks and health-care workers by personal protective equipments. Now the question arises that what we do if no effective drug or vaccine emerges? In the absence of effective drug/vaccines, pandemic has to be fought at community level not at hospitals. For such emergent situations, we need a ‘Plan B’ based non-vaccine/drug interventions.
Keywords: COVID-19, coronavirus (2019-n CoV), drug interventions, vaccine, immune system, non-drug/vaccine
Coronaviruses
Title:Controlling Coronavirus Infection: ‘Plan B’ Based on Non-vaccine / Drug Interventions
Volume: 2 Issue: 11
Author(s): Ram Kumar Dhaked*
Affiliation:
- Biotechnology Division, Defence Research & Development Establishment, Ministry of Defence, Govt. of India, Jhansi Road, Gwalior - 474002,India
Keywords: COVID-19, coronavirus (2019-n CoV), drug interventions, vaccine, immune system, non-drug/vaccine
Abstract: COVID-19 pandemic affected over 227 countries with more than 147 million infections that claimed 31.22 lacs lives. The first case of the pandemic was reported from China in Dec, 2019 showing pneumonia like symptoms that turned out to be the novel strain of coronavirus (2019-n- CoV). The WHO declared 2019-nCoV infection as the Public Health Emergency of International Concern and the disease named coronavirus disease (COVID-19). The infection curve of the pandemic has been flattened in many countries around the world, but the effective new antiviral drugs or vaccine has not yet developed. So far, we are saved by non-pharmaceutical interventions like handwashing, social distancing, quarantine, masks and health-care workers by personal protective equipments. Now the question arises that what we do if no effective drug or vaccine emerges? In the absence of effective drug/vaccines, pandemic has to be fought at community level not at hospitals. For such emergent situations, we need a ‘Plan B’ based non-vaccine/drug interventions.
Export Options
About this article
Cite this article as:
Dhaked Kumar Ram *, Controlling Coronavirus Infection: ‘Plan B’ Based on Non-vaccine / Drug Interventions, Coronaviruses 2021; 2 (11) : e310821191744 . https://dx.doi.org/10.2174/2666796702666210223155638
DOI https://dx.doi.org/10.2174/2666796702666210223155638 |
Print ISSN 2666-7967 |
Publisher Name Bentham Science Publisher |
Online ISSN 2666-7975 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Seroprevalence of Pertussis Antibodies and Infection Risk Among Female
Medical Students
New Emirates Medical Journal Post-COVID-19 Pulmonary Hypertension: How it May Physiologically Affect Exercise Training
Current Respiratory Medicine Reviews Pharmacophore-Based Discovery of New Human Dihydroorotate Dehydrogenase Inhibitor
Medicinal Chemistry Transforming Viral Sequences to A (H1N1) Flu Diagnosis: The Current Status and Future Prospects of rtPCR Based Assays
Current Pharmaceutical Biotechnology Structural Understanding of SARS-CoV-2 Drug Targets, Active Site Contour Map Analysis and COVID-19 Therapeutics
Current Molecular Pharmacology The WWW as a Tool to Obtain Molecular Parameters
Mini-Reviews in Medicinal Chemistry Promotion of Apoptosis in Cancer Cells by Selective Purine-Derived Pharmacological CDK Inhibitors: One Outcome, Many Mechanisms
Current Pharmaceutical Design Anti-Inflammatory Iridoids of Botanical Origin
Current Medicinal Chemistry Deep Learning in the Quest for Compound Nomination for Fighting COVID-19
Current Medicinal Chemistry Computational Modeling of Structure-Function of G Protein-Coupled Receptors with Applications for Drug Design
Current Medicinal Chemistry Prospective Medicines against the Widespread, Emergent, and Multidrugresistant Opportunistic Fungal Pathogen Candida auris: A Breath of Hope
Current Topics in Medicinal Chemistry The Effects of Curcumin on Immune Responses
Current Bioactive Compounds Olive Oil Consumption can Prevent Non-communicable Diseases and COVID-19: A Review
Current Pharmaceutical Biotechnology Superoxide Dismutase Inhibitors against Malaria, Leishmaniasis, and Chagas Disease: Systematic Review
Current Drug Targets Antiangiogenesis Drug Design: Multiple Pathways Targeting Tumor Vasculature
Current Medicinal Chemistry Assessment of Functional and Biological Compatibility of Antenna in a Head-Mountable DBS Device Using a Rat Model
Neuroscience and Biomedical Engineering (Discontinued) Designing Multiple Ligands – Medicinal Chemistry Strategies and Challenges
Current Pharmaceutical Design New Coronavirus Outbreak
Current Pharmaceutical Analysis Cytosporones and Related Compounds, A Review: Isolation, Biosynthesis, Synthesis and Biological Activity of Promising Fungal Resorcinolic Lipids
Current Organic Synthesis Tachykinin Receptors as Therapeutic Targets in Stress-Related Disorders
Current Pharmaceutical Design